AI assistant
Sending…
Pulmonx Corp — Director's Dealing 2023
Sep 27, 2023
34428_dirs_2023-09-26_9f254d80-944e-4fc3-bd2d-2d8da065994d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Pulmonx Corp (LUNG)
CIK: 0001127537
Period of Report: 2023-09-22
Reporting Person: Rose Geoffrey Beran (Chief Commercial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-09-22 | Common Stock | S | 1184 | $10.51 | Disposed | 251837 | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 24, 2023.
More from Pulmonx Corp
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 4
Annual Report
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 22
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2025
Dec 11
Director's Dealing
2025
Dec 9
Regulatory Filings
2025
Dec 9
Director's Dealing
2025
Dec 4
Director's Dealing
2025
Dec 4